Discovery of a potent PROTAC degrader for RNA demethylase FTO as antileukemic therapy
2024 · Acta Pharmaceutica Sinica B · 18 citations
https://doi.org/10.1016/j.apsb.2024.07.016
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
2
Papers
22
Citations
2
h-index
1
i10-index
Yuanlai Qiu is an academic researcher from University of Chinese Academy of Sciences. The author has contributed to research in topics: RNA modifications and cancer & Galectins and Cancer Biology & Peptidase Inhibition and Analysis. The author has an h-index of 2, co-authored 2 publications.
Click to start Chat